- Home
- ELUT vs JMM Comparison
ELUT vs JMM Comparison
Compare ELUT & JMM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ELUT | JMM |
|---|---|---|
| Founded | 2015 | 1988 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Trusts Except Educational Religious and Charitable |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 48.3M | 55.8M |
| IPO Year | 2020 | N/A |
Fundamental Metrics
Financial Performance| Metric | ELUT | JMM |
|---|---|---|
| Price | $1.00 | $5.76 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $6.00 | N/A |
| AVG Volume (30 Days) | ★ 128.1K | 14.5K |
| Earning Date | 05-08-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 5.44% |
| EPS Growth | ★ 146.77 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $12,293,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $10.83 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.50 | $5.67 |
| 52 Week High | $2.60 | $6.52 |
Technical Indicators
Market Signals| Indicator | ELUT | JMM |
|---|---|---|
| Relative Strength Index (RSI) | 41.93 | 46.77 |
| Support Level | $1.00 | $5.70 |
| Resistance Level | $1.18 | $5.88 |
| Average True Range (ATR) | 0.09 | 0.05 |
| MACD | -0.01 | 0.01 |
| Stochastic Oscillator | 15.15 | 50.00 |
Price Performance
Historical ComparisonAbout ELUT Elutia Inc.
Elutia Inc develops proprietary drug-eluting biomatrix products for use in surgical reconstruction and related applications. These products are designed to improve the interaction between implanted medical devices and patients. Its products include CanGaroo, designed for implantable electronic devices, and SimpliDerm, used in soft tissue repair, with functions related to implant support and wound management. The company operates in two segments: Women's Health and Cardiovascular. The majority of revenue is derived from the Women's Health segment.
About JMM Nuveen Multi-Market Income Fund (MA)
Nuveen Multi-Market Income Fund is a United States-based closed-end management investment company. The investment objective of the company is to provide high monthly income consistent with prudent risk to capital. The fund predominantly invests in debt securities, including, but not limited to, residential and commercial mortgage-backed securities, asset-backed securities, corporate debt obligations, convertible debt securities, U.S. government securities, and other such fixed income instruments. It may also invest in preferred stocks.